These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5393915)

  • 1. [Inactivation of the thyroid-stimulating and exophthalmogenic effect of TSH, LATS, EPF, thyroid antibodies and serum protein fractions by iodine].
    Schemmel K; Streich D; Kreysing G; Leybold K; Weisbecker L
    Klin Wochenschr; 1969 Aug; 47(16):879-83. PubMed ID: 5393915
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
    Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
    Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
    [No Abstract]   [Full Text] [Related]  

  • 3. Heterogeneity of long acting thyroid stimulating (LATS)-activity, thyroglobulin antibodies and thyroid microsomal antibodies.
    Adlkofer F; Schleusener H; Uher L; Ananos A
    Acta Endocrinol (Copenh); 1973 Jul; 73(3):483-8. PubMed ID: 4740843
    [No Abstract]   [Full Text] [Related]  

  • 4. TSH- or LATS-stimulated thyroid hormone release is inhibited by iodide.
    Ochi Y; DeGroot LJ
    Endocrinology; 1969 Jun; 84(6):1305-9. PubMed ID: 5781122
    [No Abstract]   [Full Text] [Related]  

  • 5. LATS and thyroid autoantibodies.
    Beall GN; Solomon DH
    Clin Exp Immunol; 1968 Sep; 3(7):615-9. PubMed ID: 4883066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the thyroid-stimulating globulin (LATS) by particulate and soluble cell fractions.
    Benhamou-Glynn N; el-Kabir DJ; Doniach D; Roitt IM
    Proc R Soc Med; 1968 Dec; 61(12):1303-5. PubMed ID: 4178461
    [No Abstract]   [Full Text] [Related]  

  • 7. Thyroid-stimulating activity in the serum of rabbits immunized with thyroid microsomes.
    Beall GN; Solomon DH
    J Clin Endocrinol Metab; 1968 Apr; 28(4):503-10. PubMed ID: 4868496
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the interaction of long-acting thyroid stimulator (LATS) with soluble thyroid fractions.
    Amino N; Miyai K; Azukizawa M; Kumahara Y
    Acta Endocrinol (Copenh); 1971 Dec; 68(4):625-44. PubMed ID: 5171628
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypothyroidism after treatment with sodium iodide I-131. Incidence and relationship to antithyroid antibodies, long-acting thyroid stimulator (LATS), and infiltrative ophthalmopathy.
    Burke G; Silverstein GE
    JAMA; 1969 Nov; 210(6):1051-8. PubMed ID: 4900342
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative effects of thyrotrophin and long-acting thyroid stimulator on iodide trapping in isolated thyroid cells.
    Burke G; Kowalski K
    Acta Endocrinol (Copenh); 1971 Dec; 68(4):645-56. PubMed ID: 5171629
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos.
    Friis T
    Dan Med Bull; 1969 Nov; 16(10):294-304. PubMed ID: 5392781
    [No Abstract]   [Full Text] [Related]  

  • 13. A COMPARISON OF THE HEAT STABILITY OF LONG-ACTING THYROID STIMULATOR AND HUMAN THYROID-STIMULATING HORMONE.
    MCGIVEN AR; ADAMS DD; PURVES HD
    J Endocrinol; 1965 Apr; 32():29-33. PubMed ID: 14275678
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperthyroidism in Tasmania following iodide supplementation: measurements of thyroid-stimulating autoantibodies and thyrotropin.
    Adams DD; Kennedy TH; Stewart JC; Utiger RD; Vidor GI
    J Clin Endocrinol Metab; 1975 Aug; 41(2):221-8. PubMed ID: 51028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
    Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
    Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of iodide on thyroid stimulation.
    Burke G
    J Clin Endocrinol Metab; 1970 Jan; 30(1):76-84. PubMed ID: 5409536
    [No Abstract]   [Full Text] [Related]  

  • 17. Interactions of adrenergic blocking drugs with the in vivo release of thyroid hormone induced by thyrotrophin and the long-acting thyroid stimulator.
    Melander A
    Acta Endocrinol (Copenh); 1971 Jan; 66(1):151-61. PubMed ID: 4395421
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative effects of immunization of rabbits with human thyroglobulin and human and rabbit thyroid microsomal fractions.
    Beall GN; Chopra IJ; Solomon DH
    Clin Exp Immunol; 1971 Apr; 8(4):647-56. PubMed ID: 5576294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of long-acting thyroid stimulator in vivo.
    Smith BR; Munro DS
    J Endocrinol; 1972 Jan; 52(1):189-96. PubMed ID: 5061150
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental production of a thyroid-stimulating antithyroid antibody.
    McKenzie JM
    J Clin Endocrinol Metab; 1968 May; 28(5):596-602. PubMed ID: 4172455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.